David Berman
Chief Tech/Sci/R&D Officer at IMMUNOCORE HOLDINGS PLC
Net worth: - $ as of 30/03/2024
Profile
David Berman is currently the Head of Research & Development at Immunocore Holdings Plc.
Prior to this, he was the Head of Immuno Oncology at Bristol Myers Squibb Co. from 2005 to 2015, the Head of Early Stage Oncology Program at MedImmune LLC from 2015 to 2017, and the Head of Immuno Oncology Franchise at AstraZeneca PLC from 2017 to 2018.
Berman received his undergraduate degree from Massachusetts Institute of Technology and his graduate and doctorate degrees from The University of Texas Southwestern Medical Center.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IMMUNOCORE HOLDINGS PLC
-.--% | 27/02/2024 | 0 ( -.--% ) | - $ | 30/03/2024 |
David Berman active positions
| Companies | Position | Start |
|---|---|---|
| IMMUNOCORE HOLDINGS PLC | Chief Tech/Sci/R&D Officer | 31/12/2018 |
Former positions of David Berman
| Companies | Position | End |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 31/12/2017 |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 31/12/2016 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 31/12/2014 |
Training of David Berman
| Massachusetts Institute of Technology | Undergraduate Degree |
| The University of Texas Southwestern Medical Center | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| IMMUNOCORE HOLDINGS PLC | Health Technology |
| Private companies | 1 |
|---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
- Stock Market
- Insiders
- David Berman
